Browsing archives for September, 2019

NORML Testifies to End Employment Discrimination of MMJ Patients in DC

Generic 28 September 2019 | 0 Comments

On Wednesday, September 25th, 2019, NORML testified at the DC Council Committee on Labor and Workforce Development in support of B23-0309, the “Medical Marijuana Program Patient Employment Protection Amendment Act of 2019”, which seeks to expand workplace protections for medical cannabis patients in the District of Columbia.  Dozens of District residents, medical cannabis patients, and advocates […]

Tagged in ,

CDC Provides Update on Lung Illnesses Linked to Vape Cartridges

Generic 28 September 2019 | 0 Comments

Updated data provided today by the US Centers for Disease Control reports over 800 cases of acute respiratory distress linked to the use of portable vapor cartridges used to consume certain e-liquids. According to the latest totals, “Among patients with data on substances used in e-cigarettes, or vaping products, tetrahydrocannabinol (THC)-containing product use was reported […]

Tagged in , , ,

House Members Pass Historic Legislation Legitimizing Retail Cannabis Sales

Generic 26 September 2019 | 0 Comments

Members of the House of Representatives voted 321 to 103 in favor of HR 1595: The SAFE Banking Act, which amends federal law so that explicitly banks and other financial institutions may work directly with state-legal marijuana businesses.  Two-hundred and twenty-nine Democrats and 91 Republicans cast ‘yes’ votes in favor of the measure. This historic […]

Tagged in , , ,

Illinois: Clemency Available for Zero to 30 Grams, Expungement Available for Convictions of 30 to 500 Grams

Generic 24 September 2019 | 0 Comments

On June 25, 2019, Governor JB Pritzker signed into law a revision of the Illinois Cannabis Control Act, 720 ILCS 550.1 et seq. Commencing January 1, 2020, Illinois residents will be authorized to possess up to 30 grams of cannabis for usage as they desire.  Non-residents do not have the same exception from the criminal […]

Tagged in , , ,

Older adults with COPD more likely to use synthetic cannabinoids

Did you know that? 24 September 2019 | 0 Comments

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that’s often associated with a variety of health problems, including chronic muscle pain and insomnia. Psychoactive drug classes, like cannabinoids, are often prescribed to help reduce pain, promote sleep and decrease breathlessness. A study has found that older adults with COPD were twice as likely […]

Tagged in